Genzyme Corporation is recalling 9,343 vials of Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection due to an issue where the package insert is either incorrect or missing entirely. Clolar is a prescription medication used for intravenous injection, and having accurate labeling is critical for safe administration. If you or a family member are using this medication, it is important to verify the lot numbers against those affected by this recall. You should contact your healthcare provider or pharmacist immediately to discuss your treatment and ensure you have the correct prescribing information.
A missing or incorrect package insert means that healthcare providers or patients may not have access to essential safety information, dosage instructions, or potential side effects, which could lead to improper use of the medication.
Contact healthcare provider and return product for refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.